Innovations

Maternova conducts ongoing research into new tools that save lives. In the Innovation Index we post tools on the market and those still in research and development. We cover light, power, transport, structures, systems, IT, devices, vaccines, you name it. Innovation that saves maternal and newborn lives from every angle.

  • May 04, 2012

    Researchers at Case Western Reserve University have determined frequent gingival bleeding due to periodontal infection during pregnancy can lead to oral bacteria entering the mother's bloodstream and invading the uterus, leading to pregnancy complications. Current studies of single or multiple treatments have either been ineffective or too costly for low-resource settings. Therefore, researchers are proposing a pilot randomized control study to test the efficacy of daily antibacterial mouth rinse on pregnancy and birth outcome. There will be 400 pregnant women in the study from Ning-Qiang County in Shaanxi Province from China. The mouth rinse method is potentially a low cost and effective way to reduce preterm low birth weight due to pregnancy complications.

  • symptek, symptek homemade foam models
    April 18, 2012

    The SYMPTEK homemade foam models are low-cost, portable, human-like models for emergency obstetric training and client education. The models can be made by trainees and facilitators with minimal training using high-density latex foam readily available in low-resource settings. This foam allows practice with surgical suturing and other compression procedures. The foam models include perineal, uterine, and other pelvic models and can be sculpted in minutes. The foam is easily cleaned and can be used repeatedly. The perineal models can be used for teaching speculum examinations, repairing cervical tears, and making episiotomies and repairing them. The postpartum uterine foam model can be used to train in cord traction, removal of the placenta, and condom tamponade.

  • NIFTY, neonatal intuitive feeding technology, NIFTY infant feeding cup
    April 17, 2012

    PATH has collaborated with the University of Washington, Seattle Children's Craniofacial Center and Komfo Anokye Teaching Hospital in Kumasi, Ghana to develop the Neonatal Intuitive Feeding TechnologY (NIFTY) cup. The NIFTY cup is an inexpensive, easy to use, efficient prototype technology used to deliver breast milk or formula to infants that are unable to breastfeed. The cup is able to catch hand-expressed breast milk directly and feed the infant. NIFTY is intended to be used by caregivers, community health workers, and midwives using pictorial instructions as an aid for the already intuitive device. Currently, the developers are conducting an inventory of infant cup feeding options, determining product specifications, and creating a prototype.

  • April 17, 2012

    Quantamerix is developing a low-cost diagnostic for newborn screening of diseases, particularly inherited metabolic disorders. Their focus is on low-resource settings in China that cannot sustain the specialized infrastructure or administrative burden for traditional screening. The technology is disposable, inexpensive, and reader-less, and as easy to use as a thermometer. In February 2012, Quantamerix placed 2nd in Life Sciences track of MIT $100K ACCELERATE Competition. They also received the MIT IDEAS Global Challenge Grant and advanced to the semifinal round of MIT $100K Business Plan Contest.

  • ADAPT, automatically deflating air postpartum tamponade, "balloon tamponade",
    April 16, 2012

    Students at Johns Hopkins have developed the Automatically Deflating Air Postpartum Tamponade (ADAPT) to manage postpartum hemorrhage (PPH) in low-resource settings. ADAPT is the first air-inflated tamponade and is low-cost, sterile, and automatically-deflating. It contains a balloon which is inflated in the uterus to provide and release pressure along the uterine wall, causing the uterus to contract to its normal state while maintaining pressure against the uterine wall. ADAPT costs less than $10 and can be used in emergency care situations. Currently, ADAPT is being tested in animal studies, with human trials beginning in 2013. The ADAPT team was recently a winner of the Dell Social Innovation Challenge.

  • valid nutrition, therapeutic food, malnutrition in Africa, RUTF,
    April 16, 2012

    Valid Nutrition is an Irish company that manufactures and distributes ready-to-use therapeutic foods to prevent severe acute malnutrition to communities in Africa. The food is in the form of a paste in a sachet pack and is made of highly fortified grains, pulses, seeds, milk powder, sugar, oil, vitamins, and minerals. The paste is precooked and is eaten directly from the pack. Due to the oil base, the pastes can be stored for up to one year without refrigeration. The paste contains proteins, fats, carbohydrates and 26 nutrients. Valid Nutrition's food is sold to local NGOs and African-based charities. The costs are subsidized by donations to Valid Nutrition.

  • DIIME, hemafuse, autologous blood transfusion, soup ladle,
    April 20, 2012

    DIIME has developed a mechanical autologous transfusion device in conjunction with clinicians at the Komfo Anokye Teaching Hospital in Kumasi, Ghana called Hemafuse. The device is meant to replace traditional autologous blood transfusions done commonly in developing countries where there are shortages of donated blood. Traditionally, the patient's own blood is filtered through gauze and mixed with anti-coagulant, often leading to severe complications. Hemafuse is a handheld, reusabale device that is a safer alternative to transfusions, specifically to address ruptured ectopic pregnancies. During surgery, the tip of the device is inserted into the patient's abdomen and blood is removed through manual suction. A filter removes clots and particulates.